Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.

PubWeight™: 2.04‹?› | Rank: Top 2%

🔗 View Article (PMC 2883977)

Published in Global Health on May 25, 2010

Authors

Brenda Waning1, Margaret Kyle, Ellen Diedrichsen, Lyne Soucy, Jenny Hochstadt, Till Bärnighausen, Suerie Moon

Author Affiliations

1: Department of Family Medicine, Boston University School of Medicine, One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA. bwaning@bu.edu.

Articles citing this

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc (2010) 2.25

Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl) (2013) 1.68

A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme. J Public Health Policy (2014) 1.54

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr (2010) 1.48

A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries. Global Health (2011) 1.44

The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysis. PLoS One (2013) 1.04

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth? PLoS One (2011) 0.97

Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health Policy Plan (2011) 0.82

Human Resources for Treating HIV/AIDS: Are the Preventive Effects of Antiretroviral Treatment a Game Changer? PLoS One (2016) 0.79

Strategies for price reduction of HIV medicines under a monopoly situation in Brazil. Rev Saude Publica (2016) 0.79

Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatment. PLoS Med (2014) 0.78

Affordability of adult HIV/AIDS treatment in developing countries: modelling price determinants for a better insight of the market functioning. J Int AIDS Soc (2016) 0.77

PEPFAR Transitions to Country Ownership: Review of Past Donor Transitions and Application of Lessons Learned to the Eastern Caribbean. Glob Health Sci Pract (2015) 0.75

Trends in medicines procurement by the Brazilian federal government from 2006 to 2013. PLoS One (2017) 0.75

Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? BMC Public Health (2014) 0.75

Understanding health systems, health economies and globalization: the need for social science perspectives. Global Health (2012) 0.75

Articles cited by this

Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002. IAPAC Mon (2002) 6.33

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS (2006) 5.13

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet (2004) 4.81

Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand. AIDS (2007) 3.27

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases. Bull World Health Organ (2009) 2.85

Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. PLoS Med (2007) 2.85

HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare? PLoS One (2007) 2.74

Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ (2005) 2.54

Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens. AIDS (2007) 1.94

The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund. Bull World Health Organ (2006) 1.94

Fixed-dose combinations of antituberculous medications to prevent drug resistance. Ann Intern Med (1995) 1.74

Factors influencing global antiretroviral procurement prices. BMC Public Health (2009) 1.16

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations. Antiviral Res (2008) 1.07

Articles by these authors

Human resources and health outcomes: cross-country econometric study. Lancet (2004) 8.34

High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science (2013) 8.24

Health workers and vaccination coverage in developing countries: an econometric analysis. Lancet (2007) 7.90

Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol (2007) 6.81

Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study. Lancet (2011) 5.58

Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science (2013) 5.01

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08

Precommitting to serve the underserved. Am J Bioeth (2012) 3.95

Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ (2009) 3.77

Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. Int J Epidemiol (2009) 3.42

Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology (2014) 3.39

Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ (2010) 2.72

Governance challenges in global health. N Engl J Med (2013) 2.33

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc (2010) 2.25

Gender, migration and HIV in rural KwaZulu-Natal, South Africa. PLoS One (2010) 1.96

Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials (2013) 1.91

Driving a decade of change: HIV/AIDS, patents and access to medicines for all. J Int AIDS Soc (2011) 1.88

Age-specific mortality patterns in HIV-infected individuals: a comparative analysis of African community study data. AIDS (2007) 1.87

In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff (Millwood) (2012) 1.84

Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS (2013) 1.82

Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med (2013) 1.73

The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS One (2011) 1.67

Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS One (2009) 1.62

Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS (2014) 1.58

The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS (2012) 1.55

A new general biomarker-based incidence estimator. Epidemiology (2012) 1.55

Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review. BMC Public Health (2012) 1.52

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr (2010) 1.48

A Simplified Formula for Inferring HIV Incidence from Cross-Sectional Surveys Using a Test for Recent Infection. AIDS Res Hum Retroviruses (2009) 1.46

Mortality levels and trends by HIV serostatus in rural South Africa. AIDS (2007) 1.46

Social exposure to an antiretroviral treatment programme in rural KwaZulu-Natal. Trop Med Int Health (2011) 1.45

Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa. PLoS One (2012) 1.41

The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level--a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health (2012) 1.38

HIV and aging--preparing for the challenges ahead. N Engl J Med (2012) 1.37

Ageing with HIV in South Africa. AIDS (2011) 1.37

Do age-disparate relationships drive HIV incidence in young women? Evidence from a population cohort in rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2014) 1.33

Using age-specific mortality of HIV infected persons to predict anti-retroviral treatment need: a comparative analysis of data from five African population-based cohort studies. Trop Med Int Health (2012) 1.32

Age-gaps in sexual partnerships: seeing beyond 'sugar daddies'. AIDS (2011) 1.29

Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS (2014) 1.28

National HIV prevalence estimates for sub-Saharan Africa: controlling selection bias with Heckman-type selection models. Sex Transm Infect (2012) 1.26

Twelve myths about systematic reviews for health system policymaking rebutted. J Health Serv Res Policy (2013) 1.22

Aging with HIV in Africa: the challenges of living longer. AIDS (2012) 1.21

Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa*. Trop Med Int Health (2009) 1.21

The global health system: actors, norms, and expectations in transition. PLoS Med (2010) 1.19

Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act. Health Aff (Millwood) (2011) 1.19

The prevalence and clinical presentation of antenatal depression in rural South Africa. J Affect Disord (2011) 1.16

Barriers to treatment access for Chagas disease in Mexico. PLoS Negl Trop Dis (2013) 1.15

Assessing the effect of HIV counselling and testing on HIV acquisition among South African youth. AIDS (2013) 1.08

Reply to 'Should biomarker estimates of HIV incidence be adjusted?'. AIDS (2009) 1.06

Male circumcision to cut HIV risk in the general population. Lancet (2007) 1.06

Design of an impact evaluation using a mixed methods model--an explanatory assessment of the effects of results-based financing mechanisms on maternal healthcare services in Malawi. BMC Health Serv Res (2014) 1.05

Adjusting HIV prevalence for survey non-response using mortality rates: an application of the method using surveillance data from Rural South Africa. PLoS One (2010) 1.04

Constructing the cascade of HIV care: methods for measurement. Curr Opin HIV AIDS (2016) 1.04

Three approaches to causal inference in regression discontinuity designs. Epidemiology (2015) 1.03

Population-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverage. PLoS One (2013) 1.02

Validating child vaccination status in a demographic surveillance system using data from a clinical cohort study: evidence from rural South Africa. BMC Public Health (2011) 1.02

Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study. Lancet Glob Health (2014) 1.01

The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine (2011) 1.00

Health systems integration of sexual and reproductive health and HIV services in sub-Saharan Africa: a scoping study. J Acquir Immune Defic Syndr (2014) 0.99

Patient satisfaction with HIV and TB treatment in a public programme in rural KwaZulu-Natal: evidence from patient-exit interviews. BMC Health Serv Res (2014) 0.99

The global health system: linking knowledge with action--learning from malaria. PLoS Med (2010) 0.98

Interventions for hiring, retaining and training district health systems managers in low- and middle-income countries. Cochrane Database Syst Rev (2013) 0.98

Does enrollment status in community-based insurance lead to poorer quality of care? Evidence from Burkina Faso. Int J Equity Health (2013) 0.98

Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study. Hum Resour Health (2012) 0.95

Health workers at the core of the health system: framework and research issues. Health Policy (2011) 0.95

Are social support and HIV coping strategies associated with lower depression in adults on antiretroviral treatment? Evidence from rural KwaZulu-Natal, South Africa. AIDS Care (2014) 0.95

Community health workers to improve antenatal care and PMTCT uptake in Dar es Salaam, Tanzania: a quantitative performance evaluation. J Acquir Immune Defic Syndr (2014) 0.94

Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa. AIDS (2013) 0.94

Towards comprehensive women's healthcare in sub-Saharan Africa: addressing intersections between HIV, reproductive and maternal health. J Acquir Immune Defic Syndr (2014) 0.94

Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa. AIDS Patient Care STDS (2011) 0.94

Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis. AIDS Behav (2014) 0.93

Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Curr Opin HIV AIDS (2015) 0.93

Health worker preferences for community-based health insurance payment mechanisms: a discrete choice experiment. BMC Health Serv Res (2012) 0.90

Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness. AIDS (2016) 0.90

False beliefs about ART effectiveness, side effects and the consequences of non-retention and non-adherence among ART patients in Livingstone, Zambia. AIDS Behav (2013) 0.90

Interviewer identity as exclusion restriction in epidemiology. Epidemiology (2011) 0.89

Provider payment in community-based health insurance schemes in developing countries: a systematic review. Health Policy Plan (2012) 0.89

Conceptual and methodological challenges to measuring political commitment to respond to HIV. J Int AIDS Soc (2011) 0.89

Study-design selection criteria in systematic reviews of effectiveness of health systems interventions and reforms: A meta-review. Health Policy (2012) 0.88

Socioeconomic disparities in sexually transmitted infections among young adults in the United States: examining the interaction between income and race/ethnicity. Sex Transm Dis (2013) 0.87

The role of the health system in HIV treatment-as-prevention. AIDS (2010) 0.86

Time and Money: The True Costs of Health Care Utilization for Patients Receiving "Free" HIV/Tuberculosis Care and Treatment in Rural KwaZulu-Natal. J Acquir Immune Defic Syndr (2015) 0.85

Do self-assessments of health predict future mortality in rural South Africa? The case of KwaZulu-Natal in the era of antiretroviral treatment. Trop Med Int Health (2012) 0.85

Indicators of political commitment to respond to HIV. Sex Transm Infect (2012) 0.84

Preventing unintended pregnancy and HIV transmission: effects of the HIV treatment cascade on contraceptive use and choice in rural KwaZulu-Natal. J Acquir Immune Defic Syndr (2014) 0.84

Partner Age-Disparity and HIV Incidence Risk for Older Women in Rural South Africa. AIDS Behav (2015) 0.83

Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health Policy Plan (2011) 0.82

Health insurance for the poor decreases access to HIV testing in antenatal care: evidence of an unintended effect of health insurance reform in Colombia. Health Policy Plan (2013) 0.81

HIV treatment cascade in migrants and mobile populations. Curr Opin HIV AIDS (2015) 0.81

Almost universal coverage: HIV testing among TB patients in a rural public programme. Int J Tuberc Lung Dis (2012) 0.80

Determinants and spatial patterns of adult overweight and hypertension in a high HIV prevalence rural South African population. Health Place (2012) 0.80

Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation. Epidemiology (2015) 0.80

Time and money: the true costs of health care utilization for patients receiving 'free' HIV/TB care and treatment in rural KwaZulu-Natal. J Acquir Immune Defic Syndr (2015) 0.79

[Human resources needed to affter health prevention and promotion to adults in primary health care]. Salud Publica Mex (2013) 0.79

Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa. AIDS (2017) 0.78

Space-time migration patterns and risk of HIV acquisition in rural South Africa. AIDS (2017) 0.78